2014 annual financial data

XTL Biopharmaceuticals 2014 Financial results

Direct answer

Revenue was 41,000 USD.

Operating income was -2,022,000 USD and net income was -2,527,000 USD.
Operating cash flow was -2,470,000 USD.

Get free XTL Biopharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
41,000 USD
Operating income
-2,022,000 USD
Net income
-2,527,000 USD
Operating cash flow
-2,470,000 USD